Lv1
98 积分 2023-09-14 加入
Kowdley KV, Minuk GY, Pagadala MR. The nonsteroidal farnesoid X receptor agonist Cilofexor improves liver biochemistry in patients with primary biliary cholangitis: a phase 2, randomized, placebo-controlled trial
1个月前
已完结
Cilofexor in non-cirrhotic primary sclerosing cholangitis (PRIMIS): a randomised, double-blind, multicentre, placebo-controlled, phase 3 trial
1个月前
已完结
皖公网安备34019202002308
